MedPath

IV dexmeditomidine prior to intubation

Not yet recruiting
Conditions
ASA I and II patients
Medical and Surgical, (2) ICD-10 Condition: O||Medical and Surgical, (3) ICD-10 Condition: O||Medical and Surgical, (4) ICD-10 Condition: O||Medical and Surgical,
Registration Number
CTRI/2021/10/037428
Lead Sponsor
Dr Waseema Kabeer
Brief Summary

It is a randomised,prospective,comparative,double blinded, observational study wherein Two doses of IV dexmeditomidine are compared for the attenuation of hemodynamic pressor response of laryngoscopy and endotracheal intubation before any surgical procedure in the operation theatre.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Age between 18-60 yr of either sex.
  • ASA grade I and grade II.
  • Patients posted for elective surgeries under general anesthesia requiring intubation.
  • Hemodynamically stable patients having all routine investigations within normal limits.
  • Patients who give written informed consent and are willing to be part of the study.
Exclusion Criteria
  • Patients refusal.
  • Patients with ASA physical status III and more.
  • Patients with any pre-existing cardiovascular disease.
  • Patients with h/o allergy to test drugs.
  • Patients posted for emergency surgeries.
  • Patients with difficult airway.
  • Patients with neurological disorders and muscle diseases.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To observe the attenuation of pressor response to laryngoscopy and endotracheal intubation with IV dexmedetomindinePRE SCOPE, AT THE TIME OF SCOPY, 0 MINS, 5 MINS, EVERY 5 MINUTES UPTO 2 HOURS, POST EXTUBATION VAS
Secondary Outcome Measures
NameTimeMethod
To observe the attenuation of pressor responses to laryngoscopy and endotracheal intubation with intravenous Dexmeditomidine 1mcg/kgPRE SCOPE, AT THE TIME OF SCOPY, 0 MINS, 5 MINS, EVERY 5 MINUTES UPTO 2 HOURS, POST EXTUBATION VAS

Trial Locations

Locations (1)

Dr. DY Patil medical college

🇮🇳

Pune, MAHARASHTRA, India

Dr. DY Patil medical college
🇮🇳Pune, MAHARASHTRA, India
Dr Waseema Kabeer
Principal investigator
9884028248
waseema040194@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.